A Study of Solid Formulations of JNJ-39393406 in Healthy Male Participants

NCT01986491 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ 39393406 30 mg solid X
DRUG: JNJ 39393406 30 mg solid Y
DRUG: JNJ 39393406 120 mg solid X
DRUG: JNJ 39393406 120 mg solid Y
DRUG: JNJ 39393406 30 mg solution

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.